Unleashing the Potential of ADCs with High-Quality Bioreagents

Description

Discover a groundbreaking webinar delving into antibody-drug conjugates (ADCs) manufacturing and the recommended strategies to overcome common challenges in potency testing and product purity. ADCs and cell/gene therapies are both advanced approaches in the field of biomedicine that aim to target and treat various diseases in innovative ways. Both rapidly evolving fields with complex landscapes, they each face significant challenges and require innovative solutions for development, scale-up and commercialization. Particularly, when it comes to ADC manufacturing, two key challenges lie in the realms of potency testing and product purity, posing obstacles to manufacturing ADCs at a larger scale and cost-effectively. Furthermore, more robust tools and streamlined processes are needed to ensure the timely production of ADCs for clinical trials and potential commercial launches. Additionally, meeting regulatory standards adds another layer of complexity to the manufacturing process. This webinar will delve into these challenges, exploring their impact and potential solutions for advancing ADC manufacturing.